These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 34132839)

  • 1. Thromboaspiration and fibrinolysis infusion for portomesenteric thrombosis after AstraZeneca COVID-19 vaccine administration.
    Barral M; Arrive L; El Mouhadi-Barnier S; Cornelis FH
    Intensive Care Med; 2021 Sep; 47(9):1034-1036. PubMed ID: 34132839
    [No Abstract]   [Full Text] [Related]  

  • 2. Diagnosis and Management of Vaccine-Related Thrombosis following AstraZeneca COVID-19 Vaccination: Guidance Statement from the GTH.
    Oldenburg J; Klamroth R; Langer F; Albisetti M; von Auer C; Ay C; Korte W; Scharf RE; Pötzsch B; Greinacher A
    Hamostaseologie; 2021 Jun; 41(3):184-189. PubMed ID: 33822348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxford-AstraZeneca COVID-19 vaccine-induced cerebral venous thrombosis and thrombocytopaenia: A missed opportunity for a rapid return of experience.
    Geeraerts T; Montastruc F; Bonneville F; Mémier V; Raposo N;
    Anaesth Crit Care Pain Med; 2021 Aug; 40(4):100889. PubMed ID: 34033927
    [No Abstract]   [Full Text] [Related]  

  • 4. COVID-19: SARS-CoV-2 Vaccine-Induced Immune Thrombotic Thrombocytopenia.
    Scharf RE; Alberio L
    Hamostaseologie; 2021 Jun; 41(3):179-182. PubMed ID: 34192777
    [No Abstract]   [Full Text] [Related]  

  • 5. COVID-19 vaccine-induced thrombosis.
    Ambrosetti M; Pontali E
    Int J Tuberc Lung Dis; 2021 Sep; 25(9):691-692. PubMed ID: 34802488
    [No Abstract]   [Full Text] [Related]  

  • 6. Thrombosis of the palmar digital vein after Oxford-AstraZeneca COVID-19 vaccination.
    Chen YA; Huang HY; Wu SH; Huang TC
    Int J Dermatol; 2021 Nov; 60(11):e469-e471. PubMed ID: 34473841
    [No Abstract]   [Full Text] [Related]  

  • 7. When is it reasonable to extrapolate during a pandemic?: The case of broad UK labeling for AstraZeneca COVID-19 vaccine.
    Dal-Ré R; Banzi R
    Eur J Intern Med; 2021 May; 87():1-2. PubMed ID: 33810939
    [No Abstract]   [Full Text] [Related]  

  • 8. Thrombosis after covid-19 vaccination.
    Hunter PR
    BMJ; 2021 Apr; 373():n958. PubMed ID: 33853865
    [No Abstract]   [Full Text] [Related]  

  • 9. Granulomatous vasculitis after the AstraZeneca anti-SARS-CoV-2 vaccine.
    Gillion V; Jadoul M; Demoulin N; Aydin S; Devresse A
    Kidney Int; 2021 Sep; 100(3):706-707. PubMed ID: 34237323
    [No Abstract]   [Full Text] [Related]  

  • 10. Benefits and risks associated with different uses of the COVID-19 vaccine Vaxzevria: a modelling study, France, May to September 2021.
    Tran Kiem C; Andronico A; Bosetti P; Paireau J; Alter L; Boëlle PY; Fontanet A; Lévy-Bruhl D; Cauchemez S
    Euro Surveill; 2021 Jul; 26(26):. PubMed ID: 34212840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of the thrombosis that can be caused by COVID-19 vaccine.
    García-Vigil JL; García-Álvarez JL
    Gac Med Mex; 2021; 157(4):449. PubMed ID: 35133344
    [No Abstract]   [Full Text] [Related]  

  • 12. Thrombosis with thrombocytopenia syndrome after COVID-19 vaccination.
    Cuker A
    Clin Adv Hematol Oncol; 2021 Jul; 19(7):446-449. PubMed ID: 34236343
    [No Abstract]   [Full Text] [Related]  

  • 13. [SARS-CoV-2 vaccine-induced immune thrombosis and thrombocytopenia].
    Hvas AM; Ostrowski SR; Frederiksen H; Kampmann P; Stensballe J
    Ugeskr Laeger; 2021 Jul; 183(29):. PubMed ID: 34356021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVAX Statement on WHO emergency use listing for AstraZeneca/Oxford COVID-19 vaccine.
    Neurosciences (Riyadh); 2021 Apr; 26(2):222-223. PubMed ID: 33814381
    [No Abstract]   [Full Text] [Related]  

  • 15. In adults, the Oxford/AstraZeneca vaccine had 70% efficacy against COVID-19 >14 d after the 2nd dose.
    Chagla Z
    Ann Intern Med; 2021 Mar; 174(3):JC29. PubMed ID: 33646835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sustained COVID-19 vaccine willingness after safety concerns over the Oxford-AstraZeneca vaccine.
    Sønderskov KM; Dinesen PT; Østergaard SD
    Dan Med J; 2021 Mar; 68(5):. PubMed ID: 33870886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amyotrophic neuralgia secondary to Vaxzevri (AstraZeneca) COVID-19 vaccine.
    Crespo Burillo JA; Loriente Martínez C; García Arguedas C; Mora Pueyo FJ
    Neurologia (Engl Ed); 2021 Sep; 36(7):571-572. PubMed ID: 34330677
    [No Abstract]   [Full Text] [Related]  

  • 18. Extensive thrombosis after COVID-19 vaccine: cause or coincidence?
    Graça LL; Amaral MJ; Serôdio M; Costa B
    BMJ Case Rep; 2021 Aug; 14(8):. PubMed ID: 34400433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrinolysis Shutdown and Thrombosis in a COVID-19 ICU.
    Creel-Bulos C; Sniecinski R
    Shock; 2021 Jun; 55(6):845-846. PubMed ID: 33989265
    [No Abstract]   [Full Text] [Related]  

  • 20. How could a COVID vaccine cause blood clots? Scientists race to investigate.
    Ledford H
    Nature; 2021 Apr; 592(7854):334-335. PubMed ID: 33846607
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.